- Filed
- Jul 11, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Jul 10, 2025 | 65.78M sh |
| Shares Diluted | Q3 2025 · May 31, 2025 | 53.2M sh |
| Shares Diluted | Q3 2025 · May 31, 2025 | 53.2M sh |
| Shares Diluted | Q3 2025 · May 31, 2024 | 53.2M sh |
| Shares Diluted | Q3 2025 · May 31, 2024 | 53.2M sh |
| Operating Cash Flow | Q3 2025 · May 31, 2025 | −$1M |
| Operating Cash Flow | Q3 2025 · May 31, 2024 | −$1.15M |
| Cash And Equivalents | Q3 2025 · May 31, 2025 | $3.24M |
| Cash And Equivalents | Q3 2025 · Aug 31, 2024 | $1.25M |
| Stockholders Equity | Q3 2025 · May 31, 2025 | $3.03M |
| Stockholders Equity | Q3 2025 · Feb 28, 2025 | $3.58M |
| Stockholders Equity | Q3 2025 · Nov 30, 2024 | $4.18M |
| Stockholders Equity | Q3 2025 · Aug 31, 2024 | $4.68M |
| Stockholders Equity | Q3 2025 · May 31, 2024 | $5.28M |
| Stockholders Equity | Q3 2025 · Feb 29, 2024 | $6.46M |
| Stockholders Equity | Q3 2025 · Nov 30, 2023 | $6.85M |
| Stockholders Equity | Q3 2025 · Aug 31, 2023 | $7.33M |
| Current Liabilities | Q3 2025 · May 31, 2025 | $390.96K |
| Current Liabilities | Q3 2025 · Aug 31, 2024 | $321.51K |
| Total Liabilities | Q3 2025 · May 31, 2025 | $390.96K |
| Total Liabilities | Q3 2025 · Aug 31, 2024 | $321.51K |
| Current Assets | Q3 2025 · May 31, 2025 | $3.41M |
| Current Assets | Q3 2025 · Aug 31, 2024 | $4.99M |
| Total Assets | Q3 2025 · May 31, 2025 | $3.43M |
| Total Assets | Q3 2025 · Aug 31, 2024 | $5M |
| Eps Diluted | Q3 2025 · May 31, 2025 | −$0.01 |
| Eps Diluted | Q3 2025 · May 31, 2025 | −$0.03 |
| Eps Diluted | Q3 2025 · May 31, 2024 | −$0.03 |
| Eps Diluted | Q3 2025 · May 31, 2024 | −$0.05 |
| Eps Basic | Q3 2025 · May 31, 2025 | −$0.01 |
| Eps Basic | Q3 2025 · May 31, 2025 | −$0.03 |
| Eps Basic | Q3 2025 · May 31, 2024 | −$0.03 |
| Eps Basic | Q3 2025 · May 31, 2024 | −$0.05 |
| Sga Expense | Q3 2025 · May 31, 2025 | $385.87K |
| Sga Expense | Q3 2025 · May 31, 2025 | $1.34M |
| Sga Expense | Q3 2025 · May 31, 2024 | $693.42K |
| Sga Expense | Q3 2025 · May 31, 2024 | $1.51M |
| Rd Expense | Q3 2025 · May 31, 2025 | $167.64K |
| Rd Expense | Q3 2025 · May 31, 2025 | $478.16K |
| Rd Expense | Q3 2025 · May 31, 2024 | $161.89K |
| Rd Expense | Q3 2025 · May 31, 2024 | $411.22K |
| Net Income | Q3 2025 · May 31, 2025 | −$545.72K |
| Net Income | Q3 2025 · May 31, 2025 | −$1.75M |
| Net Income | Q3 2025 · May 31, 2024 | −$1.46M |
| Net Income | Q3 2025 · May 31, 2024 | −$2.81M |
| Operating Income | Q3 2025 · May 31, 2025 | −$553.51K |
| Operating Income | Q3 2025 · May 31, 2025 | −$1.82M |
| Operating Income | Q3 2025 · May 31, 2024 | −$855.31K |
| Operating Income restated | Q3 2025 · May 31, 2024 | −$1.93M |
| Short Term Investments | Q3 2025 · Aug 31, 2024 | $3M |